2009 PUBLICATIONS, ABSTRACTS AND PRESENTATIONS Publications Balas M, Sinnett M, Plakogiannis R. Probable non-steroidal anti-inflammatory drug-induced periorbital edema. Case report and review of the literature. Am J Health-sys Pharm 2009. In Press Golestaneh L, Gofran A, Mokrzycki MH, Chen JL. Removal of Vancomycin in Sustained Low- efficiency Dialysis (SLED): A Need for Better Surveillance and Dosing. Clin Nephrology. 2009;72:286-91. Orsini J, Nadkarni A, Chen J, Cohen, N. Propofol Infusion Syndrome: Case Report and Literature review. Am J Health-syst Pharm. 2009;66:908-15. Garcia D, Cheng-Lai A. Dronedarone. A new antiarrhythmic agent for the treatment of atrial fibrillation. Cardiology in Review 17:230, 2009. Khalique SC, Cheng-Lai A. Drug interaction between clopidogrel and proton pump inhibitors. Cardiology in Review 2009;17:198-200. Marfo K, Lu A. Post-exposure prophylaxis of H1N1 with Oseltamivir in a newly transplanted kidney recipient receiving intense immunosuppressive therapy. Transplantation Proceedings Journal 2009; 41:4411-4413 Marfo K, Greenstein S. Management Strategies for Immunosuppressant and Antiretroviral Drug- Drug Interactions in HIV-infected Liver and Kidney Transplant Recipients. Transplantation Proceedings Journal 2009; 41:3796-3799 Marfo K, Guo Y. Pharmacoeconomic analysis of Micafungin 100 mg versus 150 mg daily in Treatment of Candidemia. Pharmacy and Therapeutics Journal 2009; 34(4):196-199 Prlesi L, Cheng-Lai A. Clevidipine. A novel ultra-short-acting calcium antagonist. Cardiology in Review 2009:17:147-152. Prlesi L, Plakogiannis R. Angioedema After NSAID Initiation in a Patient stable on an ACEI: Case Report and Review of the Literature. Am J of Health-Sys Pharm In Press Friedman, BW, Bender B, Davitt M, Solorzano C, Paternoster J, Esses D, BIjur P, Gallagher EJ. A Randomized Trial of Diphenhydramine as Prophylaxis Against Metoclopramide-Induced Akathisia in Nauseated Emergency Department Patients. Ann Emerg Med 2009 53; 379-385. Choy, M, Kovera, C., Veltri, K. Integrating Cultural Competency In A New Doctor Of Pharmacy Program In Harlem. Letter to the Editor. Hospital Pharmacy. Volume 44, Number 8, p 652. 2009
Abstracts/Posters/Presentations
P. Chung. The Strategies to Address Antimicrobial Resistance (STAAR) Act. Presentation at the New York City Society of Health-System Pharmacists Continuing Education Dinner, New York, New York, March 2009. K. Marfo. Novel Approaches: Immunosupression in Orhtotopic Liver Transplantation. New York City Society of Health System Pharmacists: Transplant Symposium. New York, New York; March, 2009. S. Khalique S, A. Cheng-Lai, P.Chung: Comparison of the incidence of hyponatremia in heart failure patients treated with and without spironolactone. Presented at the 28th annual eastern states conference for pharmacy residents and preceptors. Hershey, PA, May 2009 K. Veltri.Pharmacy-Based Immunization Delivery certificate training program American Pharmacists Association. UAN: 202-000-09-001-L01-P June- December 2009. R. Plakogiannis, Treating Beyond LDL-C Continuing Education, Sponsored by GNYHA Services. ACPE accredited Teleconference. June 2009 K. Veltri, R. Tahir., V. Sandweiss. Evaluation of Spanish-Language Learning Opportunities in a Newly Developed Doctor of Pharmacy Program.Poster Presentation. American Association of Colleges of Pharmacy. Boston, MA July 2009 K. Veltri, J. Addo-Atuah. Creative Teaching of Health Promotion in a Public Health Course for Pharmacy Students. Poster Presentation. American Association of Colleges of Pharmacy. Boston, MA July 2009 Y. Guo, P.Chung K Marfo, M. Sinnett. Pharmacoeconomic analysis of micafungin and caspofungin in treatment of candidemia and invasive candidiasis. Podium presentation at the Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, September 2009. Ostrowsky, B, Y. Guo Y, P. Chung, Leviton L. A stepwise approach to antimicrobial stewardship program-good for prescribing and fellows. Poster presentation at the Annual Infectious Diseases Society of America meeting, Philadelphia, Pennsylvania, October 2009. V. Yaghdjian, S. Simkhovich, I. Khorshidi, K. Veltri. A prospective correlation between vaccine acceptance rates in adults and the use of gender and ethnicity specific patient teaching aids in the in-patient setting. Poster Presentation. American College of Clinical Pharmacy. Anaheim, California. October 2009 K. Marfo, D.Garcia, S. Khalique, K. Berger. A. Lu. Evaluation of Medication Errors via a Computerized Physician Order Entry System in an Inpatient Renal Transplant Unit. Poster Presentation 30th Annual American College of Clinical Pharmacy Meeting (ACCP) in Anaheim, CA October, 2009 K. Marfo, J. Chen, J. Chapochnick. Short-term Evaluation of Initial Maintenance Immunosuppressive Therapy with Surolimus vs. Mycophenolic Acid in Renal Transplant Recipients. The American College of Clinical Pharmacy Annual Meeting, Anaheim CA, October 2009 V. Yaghdjian. The Standing Orders Protocol & Points of Distribution at Montefiore Medical Center GNYHA Services, Clinical Pharmacy Subcommittee, November 2009. Webcast.
P. Deshpande, J. Chen, A. Gofran, M. Murea, L. Golestaneh. Meropenem Removal in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis (SLED). The American Society of Nephrology Renal Week Conference. San Diego, CA November, 2009. B. Shoberu, J. Do, S.Wilson, K. Marfo. Impact of a Pharmacist-Run Educational Intervention on the incidence of Clostridium difficile-associated diarrhea. Poster Presentation. 44th Annual American Society of Health System Pharmacists Midyear Clinical Meeting in Las Vegas, NV December, 2009 H. Ahmad, V. Yaghdjian, B. Zaino, E. Rudnick, Y. Guo, Hospital Emergency Preparedness for Novel Influenza A (H1N1) Pandemic Poster Presentation. 44th American Society of Health- System Pharmacists Mid-Year Meeting. December 2009 Research
Meropenem Clearance in Sustained Low-Efficiency Dialysis (SLED); Received a $25,000 grant from AstraZeneca (5/06 – 2/09). (J. Chen) Pharmacoeconomic Analysis of Rabbit Anti-thymocyte Globulin Induction Therapy in Renal Transplant Recipients (K. Marfo)
Economic Benefits of Conversion From Brand-Name Mycophenolate and Tacrolimus to its Generic Bioequivalent. (K. Marfo, A Lu) Evaluating the Risk of Bleeding in Renally Compromised Patients Receiving Treatment Doses of Dalteparin for Acute Thromboembolic Disorders. (H. Billett, M. Sinnett, C. Solorzano) Comparison of Diuretic Effects Produced by Metolazone Versus Chlorothiazide in Heart Failure Patients Who Receive Concurrent Furosemide Treatment (J. Do, A. Cheng, R. Zolty) LCP-Tacro 3001: Phase 3, Open-label, Multicenter, Prospective, Randomized Study of the Efficacy and Safety of Conversion from Prograf capsules Twice Daily to LCP-Tacro tablets once daily for the prevention of acute Allograft Rejection in Stable Kidney Transplant Patients – Sub-Investigator
PRIME MINISTER MINISTER FOR HEALTH AND IMPORTANT NEW MEDICINES LISTED ON THE PBS More than 160,000 Australians per year will benefit from the Australian Government’s decision to provide subsidised access to 48 medicines, including treatments for serious heart conditions including heart failure in infants and children, rare but serious infections like tuberculosis, and
Page 1 of 3 WARFARIN Why is this medication prescribed? Warfarin is used to prevent blood clots (thrombosis) from forming or growing larger in the arteries or veins. Warfarin has an anticoagulant effect on the blood. It slows down the clotting process helping to prevent thrombosis from occurring or reoccurring. Blood clots can lead to stroke, heart attack o